Caricamento...
Bortezomib and etoposide combinations exert synergistic effects on the human prostate cancer cell line PC-3
Novel treatment modalities are urgently required for androgen-independent prostate cancer. In order to develop an alternative treatment for prostate cancer, the cytotoxic effects of the 26S proteasome inhibitor bortezomib, either alone or in combination with the two commonly used chemotherapeutic ag...
Salvato in:
| Pubblicato in: | Oncol Lett |
|---|---|
| Autori principali: | , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
D.A. Spandidos
2016
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4841005/ https://ncbi.nlm.nih.gov/pubmed/27123085 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2016.4340 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|